Published in Case Rep Ophthalmol on January 21, 2011
Orbital metastasis secondary to pulmonary adenocarcinoma treated with gefitinib: a case report. J Med Case Rep (2012) 0.82
Exophthalmos as a first manifestation of small cell lung cancer: a long-term follow-up. Case Rep Ophthalmol (2011) 0.82
Orbital metastasis as the initial presentation of lung adenocarcinoma: a case report. Onco Targets Ther (2016) 0.80
Lung cancer and eye metastases. Med Hypothesis Discov Innov Ophthalmol (2014) 0.78
Survey of 520 eyes with uveal metastases. Ophthalmology (1997) 6.55
Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Arch Ophthalmol (1974) 6.34
The incidence of ocular metastatic carcinoma. Arch Ophthalmol (1971) 3.64
Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy? J Clin Oncol (2010) 2.70
Tumor metastasis to the eye. I. Incidence in 213 adult patients with generalized malignancy. Am J Ophthalmol (1967) 2.22
Metastatic tumors to the eye and orbit. Patient survival and clinical characteristics. Arch Ophthalmol (1987) 2.20
Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China. J Thorac Oncol (2007) 2.15
Diagnosis and management of cancer metastatic to the uvea: a study of 70 cases. Ophthalmology (1979) 2.01
A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. Am J Ophthalmol (1983) 1.79
Frequency of ocular metastases in patients dying of cancer in eye bank populations. Br J Ophthalmol (1996) 1.46
Clinical characteristics of metastatic orbital tumors. Ophthalmology (1990) 1.45
Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin). Int J Radiat Oncol Biol Phys (2008) 1.38
Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy. Arch Ophthalmol (2007) 1.31
Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinib. J Thorac Oncol (2006) 1.24
Chemotherapy for eye cancer. Surv Ophthalmol (2001) 1.14
Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol (2006) 1.13
Ocular manifestations of cancer. Curr Opin Ophthalmol (1998) 1.10
Three cases of long-lasting tumor control with erlotinib after progression with gefitinib in advanced non-small cell lung cancer. J Thorac Oncol (2007) 1.07
Orbital metastasis due to interval lobular carcinoma of the breast: a potential mimic of lymphoma. Arch Ophthalmol (1999) 0.87
First-generation epidermal growth factor receptor tyrosine kinase inhibitors in EGFR mutation: positive non-small cell lung cancer patients. J Thorac Oncol (2008) 0.87
[Diplopia as first symptom of a bronchogenic carcinoma]. Klin Monbl Augenheilkd (2000) 0.83
Difficult airway and difficult intubation in postintubation tracheal stenosis: a case report and literature review. Ther Clin Risk Manag (2012) 1.18
Solitary papillomas of the lower airways: epidemiological, clinical, and therapeutic data during a 22-year period and review of the literature. J Thorac Oncol (2012) 1.18
Intensive care unit and lung cancer: when should we intubate? J Thorac Dis (2013) 1.10
Malignant pleural effusion and algorithm management. J Thorac Dis (2013) 1.09
Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer. Onco Targets Ther (2013) 1.04
Williams-Campbell syndrome: a case report. Int J Gen Med (2012) 0.97
Feasibility and effectiveness of inhaled carboplatin in NSCLC patients. Invest New Drugs (2011) 0.95
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study. Drug Des Devel Ther (2013) 0.94
Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections. Int J Gen Med (2012) 0.92
Traumatic asphyxia due to blunt chest trauma: a case report and literature review. J Med Case Rep (2012) 0.91
Hydrocarbon pneumonitis following liquid paraffin aspiration during a fire-eating performance: a case report. J Med Case Rep (2008) 0.89
A case of typical pulmonary carcinoid tumor treated with bronchoscopic therapy followed by lobectomy. J Multidiscip Healthc (2012) 0.89
Inhaled insulin: too soon to be forgotten? J Aerosol Med Pulm Drug Deliv (2011) 0.88
Platypnea and orthodeoxia associated with Pneumocystis jiroveci and Cytomegalovirus pneumonia: a case report. J Med Case Rep (2009) 0.87
Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration (2011) 0.86
New dilemmas in small-cell lung cancer TNM clinical staging. Onco Targets Ther (2013) 0.86
Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion. Am J Clin Oncol (2008) 0.84
Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report. Int J Gen Med (2011) 0.83
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis. Onco Targets Ther (2013) 0.83
Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms? BMC Res Notes (2011) 0.82
Subclavian thrombosis in a patient with advanced lung cancer: a case report. J Med Case Rep (2011) 0.81
Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome. Sleep Breath (2009) 0.80
Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it". Ther Deliv (2012) 0.79
The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature. J Chemother (2012) 0.79
Long-term prognosis of asthma is good--a 12-year follow-up study. Influence of treatment. J Asthma (2009) 0.78
In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy. Mutat Res (2012) 0.78
Utility of tissue Doppler imaging in predicting outcome in patients with idiopathic pulmonary fibrosis. Hellenic J Cardiol (2007) 0.78
Six minute walking test and carbon monoxide diffusing capacity for non-small cell lung cancer: easy performed tests in every day practice. J Thorac Dis (2012) 0.76
Community-acquired pneumonia due to Legionella pneumophila, the utility of PCR, and a review of the antibiotics used. Int J Gen Med (2011) 0.75
Oxidative and pre-inflammatory stress in wedge resection of pulmonary parenchyma using the radiofrequency ablation technique in a swine model. J Cardiothorac Surg (2012) 0.75
Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010. Int J Gen Med (2012) 0.75
A 63-year-old man with suspected lung cancer and acute renal failure. Chest (2003) 0.75
Potential prognostic value of intracellular cytokine detection by flow cytometry in pulmonary sarcoidosis. J Interferon Cytokine Res (2013) 0.75
NK cell populations in collagen vascular disease. Clin Exp Rheumatol (2012) 0.75